Skip to main content

Low Ileocecal Valve Pressure Is Significantly Associated with Small Intestinal Bacterial Overgrowth (SIBO)



Small intestinal bacterial overgrowth (SIBO) is a significant and increasingly recognized syndrome. While the development may be multifactorial, impairment of the ileocecal valve (ICV), small bowel motility, and gastric acid secretion have been hypothesized to be risk factors. ICV dysfunction remains largely unexplored using standard technology. The wireless motility capsule (WMC) that evaluates pressure, pH, and temperature throughout the GI tract provides the ability to assess these parameters.


The primary aims of this study were to assess the relationship of ICV pressures, small bowel transit time (SBTT) and intestinal pH with lactulose hydrogen breath testing (LBT) results in subjects with suspected SIBO.


We retrospectively studied consecutive patients referred to our institution for WMC and LBT from 2010–2012. Ileocecal junction pressures (IJP), as a surrogate for ICV pressures, were defined as the highest pressure over a 4-min window prior to the characteristic ileocecal pH drop. SBTT and pH were calculated and compared with LBT results.


Twenty-three patients underwent both WMC and LBT, with positive results observed in 15 (65.2 %). IJP were significantly higher in LBT(−) negative vs. LBT(+) (79.9 vs. 45.1, p < 0.01). SBTT was significantly longer in LBT(+) versus LBT(−) (5.82 vs. 3.81 h, p = 0.05). Among LBT(+) subjects, gastric pH was significantly higher versus LBT(−) subjects (2.76 vs. 1.63, p = 0.01). There was poor correlation between IJP and other parameters (SBTT, small bowel pH, and gastric pH).


Low IJP is significantly associated with SIBO. While this is physiologically plausible, to our knowledge, this is the first study to make this connection. Prolonged SBTT and higher pH are also independently associated with SIBO. Our findings add value of the WMC test as a diagnostic tool in patients with functional gastrointestinal complaints and suggest re-focus of attention on the ileocecal valve as a prominent player in intestinal disorders.

This is a preview of subscription content, access via your institution.

Fig. 1


  1. 1.

    Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59:1158–1166.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  2. 2.

    Stotzer PO, Bjornsson ES, Abrahamsson H. Interdigestive and postprandial motility in small-intestinal bacterial overgrowth. Scan J Gastroenterol. 1996;31:875–880.

    CAS  Article  Google Scholar 

  3. 3.

    Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461–1467.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth. A comprehensive review. Gastroenterol Hepatol (NY). 2007;3:112–122.

    Google Scholar 

  5. 5.

    Abu-Shanab AA, Quigley EMM. Diagnosis of small intestinal bacterial overgrowth: the challenges persist! Expert Rev Gastroenterol Hepatol. 2009;3:77–87.

  6. 6.

    Quera PR, Quigley EM, Madrid SAM. Small intestinal bacterial overgrowth. An update. Rev Med Chil. 2005;133:1361–1370.

    Article  Google Scholar 

  7. 7.

    Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am. 2010;24:943–959.

    PubMed  Article  Google Scholar 

  8. 8.

    Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006;145:557–563.

    PubMed  Article  Google Scholar 

  9. 9.

    Pimentel M, Lembo A, Chey WD, et al. TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22–32.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Ford AC, Spiegel BM, Talley NJ, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1279–1286.

    PubMed  Article  Google Scholar 

  11. 11.

    Tack J. Antibiotic therapy for the irritable bowel syndrome. N Engl J Med. 2011;364:81–82.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Lauritano EC, Gabrielli M, Scarpellini E. Small intestinal bacterial overgrowth recurrence after antibiotictherapy. Am J Gastroenterol. 2008;103:2031–2035.

    PubMed  Article  Google Scholar 

  13. 13.

    Quigley EM, Borody TJ, Phillips SF, Wienbeck M, Tucker RL, Haddad A. Motility of the terminal ileum and ileocecal sphincter in healthy humans. Gastroenterology. 1984;87:857–866.

    CAS  PubMed  Google Scholar 

  14. 14.

    Miller LS, Vegesna AK, Sampath AM. Ileocecal valve dysfunction in small intestinal bacterial overgrowth: a pilot study. World J Gastroenterol. 2012;18:6801–6808.

  15. 15.

    Dinning PG, Bampton PA, Kennedy ML, et al. Basal pressure patterns and reflexive motor responses in the human ileocolonic junction. Am J Physiol. 1999;276:G331–G340.

    CAS  PubMed  Google Scholar 

  16. 16.

    Kajimoto T, Dinning PG, Gibb DB, de Carle DJ, Cook IJ. Neurogenic pathways mediating ascending and descending reflexes at the porcine ileocolonic junction. Neurogastroenterol Motil. 2000;12:125–134.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2007;27:186–196.

    PubMed  Article  Google Scholar 

  18. 18.

    Rao S, Kuo B, McCallum RW et al. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol. 2009;7:537–544.

  19. 19.

    Tran K, Brun R, Kuo B. Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice. Therap Adv Gastroenterol. 2012;5:249–260.

  20. 20.

    Horn PS, Pesce AJ, Copeland BE. A robust approach to reference interval estimation and evaluation. Clin Chem. 1998;44:622–631.

    CAS  PubMed  Google Scholar 

  21. 21.

    Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–35.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Nasmyth DG, Williams NS. Pressure characteristics of the human ileocecal region—a key to its function. Gastroenterology. 1985;89:345–351.

  23. 23.

    Shafik AA, Ahmed IA, Shafik A, et al. Ileocecal junction: anatomic, histologic, radiologic and endoscopic studies with special reference to its antireflux mechanism. Surg Radiol Anat. 2011;33:249–256.

    PubMed  Article  Google Scholar 

  24. 24.

    Gazet RJ, Jarrett J. The ileocecal-colic sphincter. Studies in vitro, in man, monkey, cat, and dog. Br J Surg. 1964;51:368–370.

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Kumar D, Phillips SF, Brown ML. Reflux from ileum to colon in the dog. Role of external ligamentous attachments. Dig Dis Sci. 1988;33:345–352.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Kumar D, Phillips SF. The contribution of external ligamentous attachments to function of the ileocecal junction. Dis Colon Rectum. 1987;30:410–416.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39:54–59.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  28. 28.

    Shindo K, Fukumura M. Effect of H2-receptor antagonists on bile acid metabolism. J Investig Med. 1995;43:170–177.

    CAS  PubMed  Google Scholar 

  29. 29.

    Lewis SJ, Franco S, Young G, et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10:557–561.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Giannella RA, Broitman SA, Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut. 1972;13:251–256.

  31. 31.

    Riordan SM, McIver CJ, Walker BM et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol. 1996;91:1795–1803.

  32. 32.

    Corazza GR, Menozzi MG, Strocchi A et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990;98:302–309.

Download references

Conflict of interest


Author information



Corresponding author

Correspondence to Bani Chander Roland.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Roland, B.C., Ciarleglio, M.M., Clarke, J.O. et al. Low Ileocecal Valve Pressure Is Significantly Associated with Small Intestinal Bacterial Overgrowth (SIBO). Dig Dis Sci 59, 1269–1277 (2014).

Download citation


  • Small intestinal bacterial overgrowth (SIBO)
  • Ileocecal valve
  • Small bowel dysmotility
  • Small intestinal disorders
  • Diarrheal disorders